These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12624602)

  • 1. Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice.
    Brewer GJ; Ullenbruch MR; Dick R; Olivarez L; Phan SH
    J Lab Clin Med; 2003 Mar; 141(3):210-6. PubMed ID: 12624602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis.
    Brewer GJ; Dick R; Ullenbruch MR; Jin H; Phan SH
    J Inorg Biochem; 2004 Dec; 98(12):2160-7. PubMed ID: 15541506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.
    Brewer GJ; Dick RD; Grover DK; LeClaire V; Tseng M; Wicha M; Pienta K; Redman BG; Jahan T; Sondak VK; Strawderman M; LeCarpentier G; Merajver SD
    Clin Cancer Res; 2000 Jan; 6(1):1-10. PubMed ID: 10656425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
    Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer.
    Redman BG; Esper P; Pan Q; Dunn RL; Hussain HK; Chenevert T; Brewer GJ; Merajver SD
    Clin Cancer Res; 2003 May; 9(5):1666-72. PubMed ID: 12738719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of Hu-qi-yin on the bleomycin-induced pulmonary fibrosis in rats.
    Zhou XM; Zhang GC; Li JX; Hou J
    J Ethnopharmacol; 2007 May; 111(2):255-64. PubMed ID: 17188826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma.
    Cox C; Teknos TN; Barrios M; Brewer GJ; Dick RD; Merajver SD
    Laryngoscope; 2001 Apr; 111(4 Pt 1):696-701. PubMed ID: 11359142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice.
    Tanaka K; Tanaka Y; Namba T; Azuma A; Mizushima T
    Biochem Pharmacol; 2010 Sep; 80(6):920-31. PubMed ID: 20513440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of lowering copper levels with tetrathiomolybdate and zinc on mouse tumor and doxorubicin models.
    Hou G; Dick R; Zeng C; Brewer GJ
    Transl Res; 2006 Dec; 148(6):309-14. PubMed ID: 17162252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
    Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
    Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review.
    Brewer GJ; Merajver SD
    Integr Cancer Ther; 2002 Dec; 1(4):327-37. PubMed ID: 14664727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor and antiinflammatory effects of tetrathiotungstate in comparison with tetrathiomolybdate.
    Hou G; Dick R; Zeng C; Brewer GJ
    Transl Res; 2007 May; 149(5):260-4. PubMed ID: 17466925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice.
    Furonaka M; Hattori N; Tanimoto T; Senoo T; Ishikawa N; Fujitaka K; Haruta Y; Yokoyama A; Kohno N
    J Pharmacol Exp Ther; 2009 Jan; 328(1):55-61. PubMed ID: 18832650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
    Cabrera S; Gaxiola M; Arreola JL; Ramírez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A
    Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice.
    Ren YX; Zhou R; Tang W; Wang WH; Li YC; Yang YF; Zuo JP
    Acta Pharmacol Sin; 2007 Apr; 28(4):518-25. PubMed ID: 17376291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model.
    Brewer GJ; Dick R; Zeng C; Hou G
    J Inorg Biochem; 2006 May; 100(5-6):927-30. PubMed ID: 16321443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short courses of low dose dexamethasone delay bleomycin-induced lung fibrosis in rats.
    Chen F; Gong L; Zhang L; Wang H; Qi X; Wu X; Xiao Y; Cai Y; Liu L; Li X; Ren J
    Eur J Pharmacol; 2006 May; 536(3):287-95. PubMed ID: 16581064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
    Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of tetrathiomolybdate in a mouse model of multiple sclerosis.
    Hou G; Abrams GD; Dick R; Brewer GJ
    Transl Res; 2008 Nov; 152(5):239-44. PubMed ID: 19010295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice.
    Xiao JH; Zhang JH; Chen HL; Feng XL; Wang JL
    Planta Med; 2005 Mar; 71(3):225-30. PubMed ID: 15770542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.